ACRS - Aclaris Therapeutics, Inc. - SEC Form 4 Insider Trading Screener
17 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| S | 5 | +1 | +0 | +14 | +32 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-10-04 | ACRS | Tullman Stephen A. | Dir | P - Purchase | $14.00 | +7,100 | 571,471 | +1% | +$99,370 | ||||||
2018-08-23 | ACRS | Tullman Stephen A. | Dir | P - Purchase | $15.00 | +6,600 | 564,371 | +1% | +$98,985 | ||||||
2018-08-15 | ACRS | Tullman Stephen A. | Dir | P - Purchase | $15.97 | +6,250 | 557,771 | +1% | +$99,813 | ||||||
| M | 2018-06-11 | ACRS | Ali-Jackson Kamil | GC | S - Sale | $20.00 | -5,000 | 77,636 | -6% | -$100,000 | |||||
2018-05-18 | ACRS | Ali-Jackson Kamil | GC | S - Sale | $20.00 | -10,000 | 82,636 | -11% | -$200,000 | ||||||
2018-05-16 | ACRS | Powell Andrew Kenneth William | Dir | P - Purchase | $19.12 | +500 | 500 | New | +$9,560 | ||||||
2018-05-07 | ACRS | Ruffo Frank | CFO | P - Purchase | $18.22 | +1,250 | 156,865 | +1% | +$22,775 | ||||||
2018-04-06 | ACRS | Ruffo Frank | CFO | P - Purchase | $16.59 | +1,250 | 155,615 | +1% | +$20,738 | ||||||
2018-04-06 | ACRS | Tullman Stephen A. | Dir | P - Purchase | $16.54 | +26,700 | 551,521 | +5% | +$441,618 | ||||||
2018-04-06 | ACRS | Molineaux Christopher P. | Dir | S - Sale | $16.52 | -2,300 | 7,682 | -23% | -$37,996 | ||||||
2018-04-05 | ACRS | Walker Neal | Pres, CEO | P - Purchase | $16.75 | +10,000 | 897,184 | +1% | +$167,500 | ||||||
2017-08-16 | ACRS | Schiff Andrew N | Dir | P - Purchase | $23.02 | +108,601 | 634,455 | +21% | +$2,499,995 | ||||||
| M | 2017-02-28 | ACRS | Vivo Ventures Vii, LLC | 10% | S - Sale | $30.82 | -425,000 | 2,858,569 | -13% | -$13,098,000 | +4 | +3 | -3 | ||
2017-01-10 | ACRS | Mehra Anand | Dir | S - Sale | $28.25 | -750,000 | 1,539,480 | -33% | -$21,188,325 | 0 | -3 | -7 | |||
| M | 2016-11-16 | ACRS | Vivo Ventures Vii, LLC | 10% | S - Sale | $23.03 | -907,828 | 3,283,569 | -22% | -$20,908,049 | +4 | +8 | +20 | ||
| D | 2016-10-26 | ACRS | Ali-Jackson Kamil | GC | S - Sale+OE | $21.83 | -3,912 | 75,957 | -5% | -$85,399 | 0 | -3 | +31 | +32 | |
2016-10-26 | ACRS | Fmr LLC | See Remark 1, 10% | S - Sale | $21.94 | -3,750 | 2,571,354 | 0% | -$82,260 | -1 | -3 | +31 | +31 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |